ERD

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

01-03-2018

-

30-11-2020

Show more information

Organisation H. LUNDBECK AS

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

01-07-2015

-

30-04-2018

Show more information

Organisation H. LUNDBECK AS

IM2PACT | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain

01-01-2019

-

31-12-2024

Show more information

Organisation H. LUNDBECK AS

ROADMAP | Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020

01-11-2016

-

31-10-2018

Show more information

Organisation H. LUNDBECK AS

RADAR-CNS | Remote Assessment of Disease and Relapse in Central Nervous System Disorders

01-04-2016

-

31-03-2022

Show more information

Organisation H. LUNDBECK AS

EHDEN | European Health Data and Evidence Network

01-11-2018

-

31-10-2024

Show more information

Organisation H. LUNDBECK AS

IMPRiND | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060

01-03-2017

-

28-02-2022

Show more information

Organisation H. LUNDBECK AS

EU-GliaPhD | Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia

01-12-2016

-

30-06-2021

Show more information

Organisation H. LUNDBECK AS

PHAGO | Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976

01-11-2016

-

30-04-2022

Show more information

Organisation H. LUNDBECK AS

BICEPS | Beyond neuroInflammation: new Concepts to Elucidate the immune system’s vital role in Parkinson’s disease

01-11-2024

-

31-10-2028

Show more information

Organisation H. LUNDBECK AS

EBiSC2 | EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells

01-03-2019

-

28-02-2023

Show more information

Organisation H. LUNDBECK AS

PD-MitoQUANT | PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease

01-02-2019

-

31-07-2022

Show more information

Organisation H. LUNDBECK AS

SYNDEGEN | Synaptic dysfunction in Neurodegenerative Diseases

01-01-2017

-

30-06-2021

Show more information

Organisation H. LUNDBECK AS

Syn2Psy | Synaptic Dysfunction in Neuropsychiatric Disorders

01-03-2019

-

31-08-2023

Show more information

Organisation H. LUNDBECK AS

NextGenVis | Training the Next Generation of European Visual Neuroscientists for the benefit of innovation in health care and high-tech industry

01-03-2015

-

28-02-2019

Show more information

Organisation H. LUNDBECK AS

TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery

01-01-2017

-

31-12-2020

Show more information

Organisation H. LUNDBECK AS

PEARRL | Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines

01-05-2016

-

31-08-2020

Show more information

Organisation H. LUNDBECK AS

PET-AlphaSy | PET Imaging of Alpha-Synuclein Fibril Formation

01-09-2018

-

30-11-2022

Show more information

Organisation H. LUNDBECK AS

COSYN | Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders

01-01-2016

-

31-12-2020

Show more information

Organisation H. LUNDBECK AS

Projects overview

Selected filters:

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

IM2PACT | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain

ROADMAP | Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020

RADAR-CNS | Remote Assessment of Disease and Relapse in Central Nervous System Disorders

EHDEN | European Health Data and Evidence Network

IMPRiND | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060

EU-GliaPhD | Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia

PHAGO | Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976

BICEPS | Beyond neuroInflammation: new Concepts to Elucidate the immune system’s vital role in Parkinson’s disease

EBiSC2 | EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells

PD-MitoQUANT | PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease

SYNDEGEN | Synaptic dysfunction in Neurodegenerative Diseases

Syn2Psy | Synaptic Dysfunction in Neuropsychiatric Disorders

NextGenVis | Training the Next Generation of European Visual Neuroscientists for the benefit of innovation in health care and high-tech industry

TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery

PEARRL | Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines

PET-AlphaSy | PET Imaging of Alpha-Synuclein Fibril Formation

COSYN | Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders